Date published: 2026-4-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

Prickle1 Inhibitors

Prickle1 inhibitors belong to a specific chemical class that plays a crucial role in the field of molecular biology and cellular signaling pathways. These inhibitors are designed to target and modulate the activity of Prickle1, a protein that is a part of the planar cell polarity (PCP) signaling pathway in animals, including humans. The PCP pathway is essential for the proper development and organization of cells and tissues, particularly during embryonic development. Prickle1 itself is a critical component of this pathway, acting as a scaffold protein that interacts with other PCP proteins to regulate cellular processes such as cell polarization, migration, and tissue morphogenesis.

Prickle1 inhibitors are designed to interfere with the function of Prickle1, typically by binding to it and its normal interactions with other proteins in the PCP pathway. By doing so, these inhibitors can disrupt the PCP signaling cascade, leading to alterations in cellular behavior and tissue organization. This class of inhibitors has become valuable tools in research settings, allowing scientists to investigate the fundamental mechanisms underlying embryonic development, tissue regeneration, and cell polarity. Their use in laboratory experiments has shed light on the intricate processes that govern cell behavior and tissue architecture, contributing to our understanding of developmental biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Cyclopamine inhibits the Hedgehog (Hh) signaling pathway, which can indirectly influence Prickle1's role in the Wnt/planar cell polarity pathway due to crosstalk between Hh and Wnt signaling.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

DAPT is a gamma-secretase inhibitor that can affect Notch signaling, potentially altering Wnt pathway dynamics and indirectly affecting Prickle1 function.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

XAV-939 stabilizes Axin by inhibiting tankyrase, leading to beta-catenin degradation and potentially downregulating Wnt signaling and Prickle1 activity.

IC261

186611-52-9sc-3561
5 mg
$140.00
11
(1)

KY02111 promotes the degradation of beta-catenin, potentially decreasing Wnt signaling and indirectly affecting Prickle1.

Wnt-C59

1243243-89-1sc-475634
sc-475634A
sc-475634B
5 mg
10 mg
50 mg
$214.00
$326.00
$1275.00
1
(0)

LGK-974 is a Porcupine inhibitor that prevents Wnt ligand secretion and activity, which can impact Prickle1 due to its role in the Wnt pathway.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 inhibits ROCK, which is involved in cytoskeletal dynamics. Prickle1 is associated with the cytoskeleton and cell polarity, and thus Y-27632 may indirectly affect Prickle1 function.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$47.00
$143.00
$680.00
16
(1)

PD173074 is an FGFR inhibitor which can affect various signaling pathways, including those in which Prickle1 might be involved, due to the interconnected nature of signaling networks.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542 is an inhibitor of TGF-beta signaling which can impact the cellular context in which Prickle1 operates, potentially altering its function.

BI-D1870

501437-28-1sc-397022
sc-397022A
1 mg
5 mg
$92.00
$260.00
12
(1)

BI-D1870 is an inhibitor of RSK, which can influence downstream elements related to Prickle1's function in cellular processes.

PF 4708671

1255517-76-0sc-361288
sc-361288A
10 mg
50 mg
$179.00
$700.00
9
(1)

PF-4708671 is a specific inhibitor of p70 S6 kinase, which can interfere with cellular growth and proliferation pathways that may indirectly involve Prickle1.